Tag: Eli Lilly
Eli Lilly’s Stock Faces Setback After Weight-Loss Drug Sales Miss Estimates
Eli Lilly, the world’s most valuable drugmaker, saw a sharp decline in its stock price after missing quarterly sales expectations for its blockbuster weight-loss drugs, [more…]
New Weight Loss ETF Bets Big on Industry Leaders
The rising popularity of GLP-1 weight loss drugs has captured the attention of investors, leading Roundhill Investments to launch its GLP-1 & Weight Loss ETF [more…]
